نتایج جستجو برای: Brain Natriuretic Peptide Chronic Obstructive Pulmonary Disease

تعداد نتایج: 2418249  

2017
Ljiljana Andrijevic Senka Milutinov Ilija Andrijevic Daniela Jokic Marija Vukoja

BACKGROUND Cardiovascular diseases are an important cause of morbidity and mortality in chronic obstructive pulmonary disease patients. The increased inflammatory biomarker levels predict exacerbations and are associated with cardiovascular diseases in stable chronic obstructive pulmonary disease patients but their role in the settings of acute chronic obstructive pulmonary disease exacerbation...

Journal: :The Netherlands journal of medicine 2007
F Kanat H Vatansev T Teke

BACKGROUND Brain natriuretic peptide (BNP) is associated with increased myocardial stretching. This study aims to assess the effect of mild diuretics on plasma BNP levels in patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD) who have high plasma concentrations of BNP. METHODS Thirty consecutive patients with an acute exacerbation of COPD without any clinical e...

Pulmonary hypertension (PH) is an important cause of heart failure in chronic obstructive pulmonary disease (COPD). The pro brain natriuretic peptide N-terminal (NT-proBNP) has been suggested as a noninvasive marker to evaluate ventricular function. However, there is no evidence to support the use of NT-proBNP in monitoring the benefits of vasodilators in COPD induced PH. Thus, we used NT-proBN...

Pulmonary hypertension (PH) is an important cause of heart failure in chronic obstructive pulmonary disease (COPD). The pro brain natriuretic peptide N-terminal (NT-proBNP) has been suggested as a noninvasive marker to evaluate ventricular function. However, there is no evidence to support the use of NT-proBNP in monitoring the benefits of vasodilators in COPD induced PH. Thus, we used NT-proBN...

Journal: :Patologìâ 2023

Among the comorbid conditions that significantly worsen quality of life and expectancy are chronic obstructive pulmonary disease heart failure. Difficulties drug therapy mutually exclusive approaches in treatment concomitant cardiovascular pathology. Aim this study was to provide scientific evidence possible use combined LCZ696 (angiotensin receptor neprilysin inhibitor, ARNI), which contains i...

2007
I. Leonard Bernstein

1 De Bold AJ, Borenstein HB, Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981; 28:89-94 2 Adnot S, Chabrier PE, Brun-Buisson C, et al. Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia. J Appl Physiol 1988; 65:1975-88 3 McKenzie JC, Tanaka I, Inagami T, et al. Alterations in atria...

Journal: :iranian journal of pharmaceutical research 0
babak sharif-kashani lung transplantation research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, iran. ali hamraghani clinical pharmacy department, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. jamshid salamzadeh clinical pharmacy department, school of pharmacy, shahid behehshti university of medical sciences, tehran , iran. mohammad abbasinazari clinical pharmacy department, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran. majid malekmohammad chronic respiratory diseases research center, national research institute of tuberculosis and lung diseases (nritld), pharmaceutical care department,tehran,iran neda behzadnia lung transplantation research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, iran

pulmonary hypertension (ph) is an important cause of heart failure in chronic obstructive pulmonary disease (copd). the pro brain natriuretic peptide n-terminal (nt-probnp) has been suggested as a noninvasive marker to evaluate ventricular function. however, there is no evidence to support the use of nt-probnp in monitoring the benefits of vasodilators in copd induced ph. thus, we used nt-probn...

Journal: :iranian red crescent medical journal 0
rokhsareh aghili endocrine research center (firouzgar), institute of endocrinology and metabolism (hemmat campus), tehran university of medical sciences, tehran, ir iran maryam kia department of internal medicine, tehran university of medical sciences, tehran, ir iran alipasha meysamie department of community and preventive medicine, faculty of medicine, tehran university of medical sciences, tehran, ir iran seyed mojtaba aghili department of emergency medicine, imam khomeini hospital, tehran university of medical sciences, tehran, ir iran omalbanin paknejad division of pulmonology, shariati hospital, tehran university of medical sciences, tehran, ir iran; division of pulmonology, shariati hospital, poc: 1411413137, tehran, ir iran. tel: +98-2184901; fax: +98-2188633039; email:

conclusions the fev1/fev6 ratio can be used as a valid surrogate for fev1/fvc in the diagnosis of airway obstruction, especially for screening purposes in high-risk populations for copd. moreover, fev6 is an acceptable alternative for fvc in detection of restrictive pattern. results this study shows that the current cut-off points used to detect obstruction and restriction can be replaced by fe...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید